Teva Pharmaceuticals Industries Ltd.—headquartered in Israel—is one of the leading, global pharmaceutical companies committed to increasing access to quality-health solutions, and has an unparalleled impact on patients and healthcare systems worldwide.
Teva’s strategic acquisition of Actavis Generics significantly enhances the global scale of our sales and R&D platforms. Offering access to the world’s largest drug cabinet—with more than 1,800 medicines and 16,000 products—Teva has commercial presence across 80 markets, including a top-three leadership position in over 40 markets and global leadership in all key global markets. Teva employs over 57,000 people worldwide.
More information about Teva can be found on "http://www.tevapharm.com"